Aprecia Pharmaceuticals
PrivateLast Round
Debt
Jul 5, 2016
Total Funding Raised
$65M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Aprecia Pharmaceuticals is a pharmaceutical company that develops and manufactures orodispersible formulations of high-dose medications using its proprietary three-dimensional printing (3DP) ZipDose technology platform.
Sector
Healthcare & Life Sciences
Verticals
3D Printing, Biotechnology, Medical Devices, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aprecia Pharmaceuticals Comparables
Compare Aprecia Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laxxon Medical | 79% | |
| Triastek | 79% | |
| FabRx | 76% | |
Aprecia Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 5, 2016 | ||||
| Private Equity | Jan 27, 2016 | ||||
| VC Round | Nov 11, 2011 |
Key People
Founding team and executive leadership
Aprecia Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| Deerfield Management | Private Equity |
| JW Asset Management | Private Equity |
| JW Asset Management | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 241, 3.7x the trailing average.
- Jul 20, 2026
Open roles increased to 241, 371% of current headcount.
Aprecia Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aprecia Pharmaceuticals's valuation, stock price, and market status.